title: In silico analysis of the amido phosphoribosyltransferase inhibition by PY873, PY899 and a derivative of isophthalic acid.
abstract: Selectively decreasing the availability of precursors for the de novo biosynthesis of purine nucleotides is a valid approach towards seeking a cure for leukaemia. Nucleotides and deoxynucleotides are required by living cells for syntheses of RNA, DNA, and cofactors such as NADP(+), FAD(+), coenzyme A and ATP. Nucleotides contain purine and pyrimidine bases, which can be synthesized through salvage pathway as well. Amido phosphoribosyltransferase (APRT), also known as glutamine phosphoribosylpyrophosphate amidotransferase (GPAT), is an enzyme that in humans is encoded by the PPAT (phosphoribosyl pyrophosphate amidotransferase) gene. APRT catalyzes the first committed step of the de novo pathway using its substrate, phosphoribosyl pyrophosphate (PRPP). As APRT is inhibited by many folate analogues, therefore, in this study we focused on the inhibitory effects of three folate analogues on APRT activity. This is extension of our previous wet lab work to analyze and dissect molecular interaction and inhibition mechanism using molecular modeling and docking tools in the current study. Comparative molecular docking studies were carried out for three diamino folate derivatives employing a model of the human enzyme that was built using the 3D structure of Bacillus subtilis APRT (PDB ID; 1GPH) as the template. Binding orientation of interactome indicates that all compounds having nominal cluster RMSD in same active site's deep narrow polar fissure. On the basis of comparative conformational analysis, electrostatic interaction, binding free energy and binding orientation of interactome, we support the possibility that these molecules could behave as APRT inhibitors and therefore may block purine de novo biosynthesis. Consequently, we suggest that PY899 is the most active biological compound that would be a more potent inhibitor for APRT inhibition than PY873 and DIA, which also confirms previous wet lab report.
authors.affiliation: Functional Informatics Laboratory National Center for Bioinformatics, Quaid-I-Azam University, Islamabad, Pakistan.
authors.forename: Sidra
authors.initials: S
authors.lastname: Batool
authors.forename: Muhammad Sulaman
authors.initials: MS
authors.lastname: Nawaz
authors.forename: Mohammad A
authors.initials: MA
authors.lastname: Kamal
mesh_terms: D000582:Amidophosphoribosyltransferase / Q000037:antagonists & inhibitors* / Q000737:chemistry; D000595:Amino Acid Sequence; D001412:Bacillus subtilis / Q000201:enzymology; D001665:Binding Sites; D003198:Computer Simulation; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005493:Folic Acid Antagonists / Q000494:pharmacology*; D006801:Humans; D008958:Models, Molecular; D008969:Molecular Sequence Data; D010795:Phthalic Acids / Q000494:pharmacology*; D011725:Pyridines / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology*; D011799:Quinazolines / Q000494:pharmacology*; D016415:Sequence Alignment
chemical_list: C587695:2,4-diamino-6-(3,4,5-trimethoxyanilino)methylpyrido(3,2-d)pyrimidine; C587696:2,4-diamino-6-(3,4,5-trimethoxybenzyl)-5,6,7,8-tetrahydroquinazoline; D004791:Enzyme Inhibitors; D005493:Folic Acid Antagonists; D010795:Phthalic Acids; D011725:Pyridines; D011743:Pyrimidines; D011799:Quinazolines; D000582:Amidophosphoribosyltransferase